Ordering Recommendation

Aids in management of individuals receiving natalizumab therapy.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Plain red. Also acceptable: Serum separator tube (SST).

Specimen Preparation

Allow blood to clot at room temperature for 30 minutes. Separate serum from cells within 1 hour. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Test is not performed at ARUP; separate specimens must be submitted when multiple tests are ordered.

Storage/Transport Temperature

Frozen. Also acceptable: Refrigerated

Unacceptable Conditions
Remarks
Stability

Ambient: Unacceptable; Refrigerated: 2 Weeks; Frozen: 2 Weeks

Methodology

Qualitative Bridging Enzyme-Linked Immunosorbent Assay

Performed

Varies

Reported

5-10 days

Reference Interval

By report

Interpretive Data



Compliance Category

Performed by non-ARUP Laboratory

Note

Hotline History

N/A

CPT Codes

83516

Components

Component Test Code* Component Chart Name LOINC
2005594 Natalizumab Antibodies 58012-6
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Tysabri Neutralizing Antibody
  • Tysabri, Natalizumab Immunogenicity Test
Natalizumab Antibodies

Eurofins Viracor